摘要 |
The N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein n is 1, 2, 3, or 4; Z represents O, S, NR<SUP>6</SUP>, SO or SO<SUB>2</SUB>; R<SUP>1</SUP> represent hydrogen, cyano, hydroxy, or C<SUB>1-4</SUB>alkyl optionally substituted with halo, R<SUP>2</SUP> represents hydrogen, C<SUB>1-4</SUB>alkyl, or C<SUB>1-4</SUB>alkyloxy-; R<SUP>3</SUP> represents hydrogen, C<SUB>1-4</SUB>alkyl, C<SUB>1-4</SUB>alkyloxy- or R<SUP>3</SUP> combined with R<SUP>2</SUP> form together a divalent radical selected from the group consisting of -O-CH<SUB>2</SUB>- (a), -NR<SUP>7</SUP>-CH<SUB>2</SUB>- (b), -(CR<SUP>8</SUP>R<SUP>9</SUP>)<SUB>m</SUB>- (c) and -CR<SUP>10</SUP>= (d) wherein m represents 1 or 2 and R<SUP>7</SUP>, R<SUP>8</SUP>, R<SUP>9</SUP> and R<SUP>10</SUP> are each independently selected from hydrogen or C<SUB>1-4</SUB>alkyl; R<SUP>4</SUP> represents hydrogen, halo, hydroxy, cyano, amino, NR<SUP>11</SUP>R<SUP>12</SUP>, C<SUB>1-4</SUB>alkyloxy- optionally substituted with one or where possible two or three substituents selected from hydroxy and halo or R<SUP>4</SUP> represents C<SUB>1-4</SUB>alkyl optionally substituted with one or where possible two or three substituents selected from hydroxy and halo; R<SUP>5</SUP> represents hydrogen, halo, cyano, amino, phenyl, hydroxy, C<SUB>1-4</SUB>alkyloxycarbonyl, hydroxycarbonyl, NR<SUP>13</SUP>R<SUP>14</SUP> or C<SUB>1-4</SUB>alkyl substituted with one or more substituents selected from hydroxycarbonyl, phenyl, C<SUB>1-4</SUB>alkyloxy or NR<SUP>15</SUP>R<SUP>16</SUP>; R<SUP>6</SUP> represents hydrogen; R<SUP>11</SUP> and R<SUP>12</SUP> each independently represent hydrogen, C<SUB>1-4 </SUB>alkyl or C<SUB>1-4 </SUB>alkylcarbonyl-; R<SUP>13</SUP> and R<SUP>14</SUP> each independently represent hydrogen, C<SUB>1-4 </SUB>alkyl or C<SUB>1-4 </SUB>alkylcarbonyl-; R<SUP>15</SUP> and R<SUP>16</SUP> each independently represent hydrogen, C<SUB>1-4 </SUB>alkyl or C<SUB>1-4 </SUB>alkylcarbonyl-; R<SUP>17</SUP> and R<SUP>18</SUP> each independently represent hydrogen, C<SUB>1-4 </SUB>alkyl or C<SUB>1-4 </SUB>alkylcarbonyl-. |
申请人 |
JANSSEN PHARMACEUTICA N.V.;JAROSKOVA, LIBUSE;LINDERS, JOANNES, THEODORUS, MARIA;VAN DER VEKEN, LOUIS, JOZEF, ELISABETH;WILLEMSENS, GUSTAAF, HENRI, MARIA;BISCHOFF, FRANCOIS PAUL |
发明人 |
JAROSKOVA, LIBUSE;LINDERS, JOANNES, THEODORUS, MARIA;VAN DER VEKEN, LOUIS, JOZEF, ELISABETH;WILLEMSENS, GUSTAAF, HENRI, MARIA;BISCHOFF, FRANCOIS PAUL |